Cytek Biosciences's total assets for Q1 2025 were $482.60M, a decrease of -3.38% from the previous quarter. CTKB total liabilities were $102.97M for the fiscal quarter, a -0.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.